Shinya Osone

Prediction of <i>MYCN</i> Amplification in Neuroblastoma Using Serum DNA and Real-Time Quantitative Polymerase Chain Reaction

Takahiro Gotoh, Hajime Hosoi, Tomoko Iehara et al. · Journal of Clinical Oncology · 2005 · 94 citations · Full text

Fenretinide induces sustained‐activation of JNK/p38 MAPK and apoptosis in a reactive oxygen species‐dependent manner in neuroblastoma cells

Shinya Osone, Hajime Hosoi, Yasumichi Kuwahara et al. · International Journal of Cancer · 2004 · 74 citations

Chemoprevention Strategy, Apoptosis, Cell Death +17

Early-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do PGK-1 mutations contribute to vulnerability to parkinsonism?

Satoshi Sakaue, Takashi Kasai, Ikuko Mizuta et al. · npj Parkinson s Disease · 2017 · 52 citations · Full text

Antitumor Activity of Gefitinib in Malignant Rhabdoid Tumor Cells <b> <i>In vitro</i> </b> and <b> <i>In vivo</i> </b>

Yasumichi Kuwahara, Hajime Hosoi, Shinya Osone et al. · Clinical Cancer Research · 2004 · 42 citations · Full text

Potential use of procalcitonin concentrations as a diagnostic marker of the PFAPA syndrome

Takao Yoshihara, Toshihiko Imamura, Kentaro Yokoi et al. · European Journal of Pediatrics · 2006 · 41 citations

Physiology, Pathology, Diagnostic Marker +3